About Biokin
Company Founder
Innovative Pharmaceutical Company Synchronizing R&D, Production and Marketing
Innovation Being Widely Recognized
Enterprise Development Planning
Company Culture
Innovation and R&D
Innovative and Efficient R&D system
SystImmune
Baili-Bio/Baili Pharmaceutical
Clinical Dynamics
Manufacturing and Quality Control
Manufacturing System
GMP standard and quality assurance
Product and Marketing
Comprehensive Marketing System
Anesthesia
Parenteral Nutrition
Anti-Infectives
Pediatrics
Traditional Chinese Medicines
Investor Relations
Corporate Governance
Announcements & Circulars
Financial Reports
ESG
Listing Documents
Company Presentations
Investor Contacts
Contact Us
EN
中文
繁体
中文
繁体
EN
中文
繁体
中文
繁体
About Biokin
Company Founder
Innovative Pharmaceutical Company Synchronizing R&D, Production and Marketing
Innovation Being Widely Recognized
Enterprise Development Planning
Company Culture
Innovation and R&D
Innovative and Efficient R&D system
SystImmune
Baili-Bio/Baili Pharmaceutical
Clinical Dynamics
Manufacturing and Quality Control
Manufacturing System
GMP standard and quality assurance
Product and Marketing
Comprehensive Marketing System
Anesthesia
Parenteral Nutrition
Anti-Infectives
Pediatrics
Traditional Chinese Medicines
Investor Relations
Corporate Governance
Announcements & Circulars
Financial Reports
ESG
Listing Documents
Company Presentations
Investor Contacts
Contact Us
Company Presentations
Home
>
Investor Relations
>
Company Presentations
>
Investor Relations
Corporate Governance
Announcements & Circulars
Financial Reports
ESG
Listing Documents
Company Presentations
Investor Contacts
2024/08/24
Baili Tianheng 2024 interim results presentation
2023/08/06
Baili Tianheng 2023 interim results presentation
2023/03/08
Baili Tianheng 2023 Annual Results Presentation
